Sivers Semiconductors: A Transatlantic Storytelling Gap Meets a High-Stakes AI Pivot
Published on 08/29/2026 at 21:21 | Editorial boerse-global.de
The Swedish chipmaker's most pressing problem may not be its balance sheet, but a failure to speak the right language. As Sivers Semiconductors navigates a bruising stretch on the stock market, one analyst argues the company is pitching its growth narrative to the wrong audience — leaving the investors who matter most in the dark.
A Tale of Two Markets
The critique, leveled by an analyst identified as Serenity, centers on a fundamental disconnect. When US-based analysts engage with Sivers, their questions zero in on operational metrics: wafer capacity utilization, revenue and operating leverage, supply constraints, rising average selling prices, and the anticipated ramp-up of NPO/CPO and pluggable modules slated for 2028 — including the collaboration with O-Net on ELS products. Swedish investors, by contrast, gravitate toward topics like hemostasis technology, retail customers, and transceivers.
That mismatch between the company's genuine growth drivers and how it presents itself publicly could prove costly. If the capital providers who matter cannot grasp the story, the underlying potential stays locked — even when the operational numbers hold up.
Just as Sivers discovered that telling the right story to the right audience can unlock value, many UK employers face a similar disconnect — they underestimate the risks that regulators are paying closest attention to. A free Risk Assessment Toolkit with 41 ready-to-use templates and checklists helps you document workplace hazards properly and stay compliant. Download the free Risk Assessment Toolkit
The Substance Behind the Story
And those numbers do carry weight. The Q2 2026 interim report, unveiled on Thursday, revealed an order pipeline of $1.2 billion as of July 2026 — a 268 percent jump from December 2025. Management sees the company transitioning from pure development contracts (NRE) toward series production by 2027, with Jabil on board for optical 1.6T transceivers and GlobalFoundries for silicon photonics.
Recent contract wins add texture: $8.2 million from ALL.SPACE for Ka-band chips, $1.5 million from Tachyon, and $3.4 million from SemiNex. A LiDAR customer's production orders are also said to be imminent. This order flow underpins the pipeline figure, which management attributes to customer ramps and production bookings for 2027.
On the technology front, Sivers has launched a development program for next-generation light sources built on indium phosphide, targeting optical interconnects for AI-focused data centers. The company has yet to disclose technical specifications or timelines, but the strategic direction is clear: position itself in a segment currently attracting heavy global investment.
A Split-Screen Financial Picture
The Q2 numbers themselves tell a two-sided story. Net revenue landed at SEK 53.8 million, down 12 percent year-over-year, while hardware revenue climbed 18 percent on a currency-adjusted basis. Adjusted EBITDA remained negative at minus SEK 35.5 million, with an additional non-cash charge of SEK 42.9 million — tied to employer social security contributions on share-based compensation following the earlier share price surge — weighing on the results.
The financing side shows deliberate action. Sivers raised roughly SEK 825 million through directed share issues, and investor Bootstrap Europe converted a $12 million loan into equity. CEO Vathulya purchased 70,000 shares himself, lifting his holdings to 4,540,076 — a gesture that stands in contrast to the insider selling reported in recent weeks.
Market Punishment and Short-Seller Shifts
None of this cushioned the share price. The stock closed Friday at EUR 2.44, down 15 percent in a single session. Over seven trading days, the decline reaches 27 percent, though the 30-day picture shows a modest gain of 2.3 percent. The shares trade well below their 50-day average of EUR 3.94, and the RSI of 37.2 points to moderate weakness rather than oversold conditions.
The short side has been stirring too. Around a month ago, Arrowstreet Capital and Citadel Securities were listed as new public short sellers at Sivers, while D. E. Shaw unwound its position. These shifts coincide with elevated volatility — the annualized 30-day figure stands at 169 percent.
When the market punishes a company, investors scrutinise every risk — and workplace safety is no exception. Over 37,000 UK businesses use a free Health & Safety Toolkit with risk assessments and checklists covering COSHH, PUWER and the Health & Safety at Work Act 1974 to protect their people and their reputation. Get the free Health & Safety Toolkit
The Question Investors Must Answer
Whether the communication gap Serenity describes is genuinely the binding constraint — or whether persistent losses and dilution from capital raises remain the core issue regardless of which audience hears the pitch — is a question shareholders must now weigh. For a company with a $1.2 billion pipeline, a fresh AI-focused development program, and a freshly fortified balance sheet, the operational trajectory points one way. The market's verdict, at least for now, points another.
